Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Niagen Bioscience (NAGE) Amortizatization of Intangibles: 2011-2024

Historic Amortizatization of Intangibles for Niagen Bioscience (NAGE) over the last 12 years, with Dec 2024 value amounting to $151,000.

  • Niagen Bioscience's Amortizatization of Intangibles changed negligibly% to $38,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $151,000, marking a year-over-year increase of 160.64%. This contributed to the annual value of $151,000 for FY2024, which is 4.43% down from last year.
  • Per Niagen Bioscience's latest filing, its Amortizatization of Intangibles stood at $151,000 for FY2024, which was down 4.43% from $158,000 recorded in FY2023.
  • In the past 5 years, Niagen Bioscience's Amortizatization of Intangibles registered a high of $829,000 during FY2022, and its lowest value of $151,000 during FY2024.
  • Over the past 3 years, Niagen Bioscience's median Amortizatization of Intangibles value was $158,000 (recorded in 2023), while the average stood at $379,333.
  • Per our database at Business Quant, Niagen Bioscience's Amortizatization of Intangibles skyrocketed by 62.23% in 2022 and then plummeted by 80.94% in 2023.
  • Niagen Bioscience's Amortizatization of Intangibles (Yearly) stood at $399,000 in 2020, then grew by 28.07% to $511,000 in 2021, then skyrocketed by 62.23% to $829,000 in 2022, then slumped by 80.94% to $158,000 in 2023, then decreased by 4.43% to $151,000 in 2024.